Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Otherwise healthy subjects who are currently bein maintained on either methadone or
buprenorphine/naloxone for opioid maintenance therapy who have been on a stable dose for at
least 30 days will be administered BI 201335 daily to determine if a drug interaction occurs
between BI 201335 and either methadone or buprenorphine/naloxone.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Methadone Naloxone